Centre to track casual links to determine Covid-19 vaccine liability

As for Serum Institute of India's Covishield approval, the drug regulator has mentioned in conditions to be met that the firm has to submit an India-specific risk management plan

from Latest News https://ift.tt/3qlvl0D
https://ift.tt/eA8V8J https://ift.tt/2LUVdkd

• Tweet
• Share
• Share
• Share
• Share